Search Results - "Sekacheva, M. I."

CORONET online risk assessment tool and Charlson comorbidity index in predicting fatalities in cancer patients with COVID-19 by A. S. Rusanov, M. I. Sekacheva, A. A. Tyazhelnikov

“…Purpose of the study. Сomparing and evaluating the prognostic potential of the CORONET online risk assessment tool and the Charlson Comorbidity Index in…”
Get full text

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study by Poddubskaya, E. V., Sekacheva, M. I., Guryanova, A. A.

“…Immune checkpoint inhibitors (ICPIs) agents can cause endocrine immune-related adverse events (irAEs). Aim . Determine the incidence, time of onset and risk…”
Get full text

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen by Zh. R. Cherkasova, S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, M. I. Sekacheva

“…Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a…”
Get full text

Early echocardiographic alterations in cancer patients during chemotherapy by Fashafsha, Z. Z.A., Chomakhidze, P. Sh, Mesitskaya, D. F., Suvorov, A. Yu, Sekacheva, M. I., Poddubskaya, E. V., Tyukanova, E. S., Sankova, M. V., Ozova, M. A., Levina, V. D., Andreev, D. А., Kopylov, F. Yu

“…Aim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of…”
Get full text

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib by Sekacheva, M. I., Nuriev, R. I., Rozhkov, A. A., Semenkov, A. V., Bagmet, N. N., Boroda, A. M.

“…Over the past two decades, many new variants of targeted therapy for metastatic colorectal cancer (mCRC) had appeared, and significantly increased patient…”
Get full text

Features of the management of cancer patients during the COVID-19 pandemic by Sekacheva, M. I., Rusanov, A. S., Fatyanova, A. S., Boroda, A. M., Istranov, A. L., Rusanov, S. N., Babayeva, Yu. V., Poddubskaya, E. V.

“…Novel coronavirus infection, causing COVID-19, is not fully controlled for today. In periodicals, there are often reports of a high risk of severe…”
Get full text

Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by NTRK gene fusions by Artamonova, E. V., Breder, V. V., Vladimirova, L. Yu, Demidova, I. A., Imyanitov, E. N., Laktionov, К. К., Matrosova, M. P., Orlov, S. V., Rodionov, E. О., Sakaeva, D. D., Sekacheva, M. I., Smolin, A. V., Fadeeva, N. V., Filipenko, M. L.

“…The Advisory Board was held on December 24, 2021. The molecular genetic research lead specialists and national lead oncologists discussed issues of diagnosis…”
Get full text

Impact of preoperative drug therapy on the expression of angiogenesis markers in colorectal liver metastases by Varlamov, A V, Pal'tseva, E M, Sekacheva, M I, Skipenko, O G, Fedorov, D N

“…to study changes in the expression of angio- and vasculogenesis markers in colorectal adenocarcinoma metastases to the liver during combined cytotoxic and…”
Get more information

Impact of preoperative drug therapy on the expression of apoptosis markers in colorectal liver metastases by Varlamov, A V, Paltseva, E M, Sekacheva, M I, Fedorov, D N, Skipenko, O G

“…to estimate the expression of p53 protein, effector caspases-3 and -7, and the antiapoptotic protein survivin in colorectal adenocarcinoma metastases to the…”
Get more information

Impact of preoperative drug therapy on adhesion molecule expression in colorectal cancer liver metastases by Paltseva, E M, Varlamov, A V, Sekacheva, M I, Fedorov, D N, Skipenko, O G

“…To study E-cadherin and β-catenin expression in colorectal cancer (CRC) liver metastases in order to assess the impact of different drug therapy regimens on…”
Get more information

Intraduct papillar-mucinous pancreatic tumors by Ponomar', S A, Skipenko, O G, Sekacheva, M I

“…To inform the surgeons about specific morphologic criteria of pancreatic intraductal papillary mucinous neoplasm, features of diagnosis and surgical treatment…”
Get more information

Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs by Kamyshova, E S, Bobkova, I N, Sekacheva, M I

Get full text

Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice by Sekacheva, M.I., Bagmet, N.N.

“…The problem of the treatment of metastatic colorectal cancer makes us to continue for seeking new ways of severe disease treatment. Regorafenib is the newest…”
Get full text

Impact of preoperative chemotherapy on the expression of apoptosis factors in colorectal cancer liver metastases by Pal'tseva, E M, Sekacheva, M I, Fedorov, D N, Skipenko, O G

“…To study the effects of cytotoxic and targeted anti-VEGF drugs on some mechanisms of apoptosis. The effects of cytotoxic and targeted anti-VEGF drugs on the…”
Get more information

Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment by T O Skipenko, E M Paltseva, M I Sekacheva, A L Bedganian

“…More than 50% of patients with colorectal cancer (CRC) suffer from different types of metastatic lesions. Liver resection is the only radicaltreatment option,…”
Get full text

Multimodal approach to the treatment of hepatocellular carcinoma by O G Skipenko, D A Chekunov, G A Shatverian, N N Bagmet, M I Sekacheva, R S Polyakov, A L Bedzhanyan, A G Abdullaev, Ya G Moysyuk

“…Background. Hepatocellular carcinoma (HCC) is a malignancy of the liver associated with poor prognosis. The understanding of the prevalence of liver damage and…”
Get full text

Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases by M I Sekacheva, N N Bagmet, L O Polishchuk, O V Glazova, E V Zaklyazminskaya, O G Skripenko

“…Whether it is expedient and safe to add bevacizumab to preoperative treatment regimens for colorectal cancer liver metastases has been remained unclear over…”
Get full text

The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion by N N Bagmet, A L Bedzhanyan, L O Polishchuk, M I Sekacheva, G A Shatveryan, O G Skipenko

“…To treat colorectal cancer liver metastases presents still a challenge and to take tactical decisions requires the participation of a multidisciplinary team of…”
Get full text

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma by Poddubskaya, Elena V, Baranova, Madina P, Allina, Daria O, Smirnov, Philipp Y, Albert, Eugene A, Kirilchev, Alexey P, Aleshin, Alexey A, Sekacheva, Marina I, Suntsova, Maria V

“…Cholangiocarcinoma is an aggressive tumor with poor prognosis. Most of the cases are not available for surgery at the stage of the diagnosis and the best…”
Get full text

True cystic tumors of the pancreas by Skipenko, O G, Ponomar', S A, Bedzhanian, A L, Sekacheva, M I, Abdullaev, A G

“…Retrospective analysis of treatment results was carried out in 37 patients that had been treated during 1984-2009 years. Mean age of the patients was 50.7…”
Get more information